Skip to content

Extended Work Schedules, Sleep Loss and Health

Extended Work Schedules and Health: Role of Sleep Loss

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00989534
Acronym
EW and EWD
Enrollment
49
Registered
2009-10-05
Start date
2003-01-31
Completion date
2009-09-30
Last updated
2016-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep

Keywords

shift work, diabetes, Affects of shift work and sleep loss on health

Brief summary

This study aims to determine whether abnormal bodily rhythms contribute to elevate the risk of diabetes, independently of the amount of sleep loss.

Interventions

BEHAVIORALFixed restricted bedtimes

Sleep restricted to 5 hours per night for 8 nights

BEHAVIORALSleep restriction with circadian misalignment

Sleep restricted to 5 h per day for 8 days, alternating night sleep and day sleep

Sponsors

University of Chicago
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 39 Years
Healthy volunteers
Yes

Inclusion criteria

* normal healthy men and women between the ages of 21 years and 39 years (inclusive) with normal weight (i.e., body mass index under 28 kg/m2 in men, 27 kg/m2 in women) * normal findings on clinical examination, normal results on routine laboratory tests, normal EKG, normal glucose tolerance test, negative pregnancy test for women * no personal history of psychiatric or endocrine illness * no personal history of sleep disorder, usual total sleep time of at least 7 hours * only female volunteers with normal ovulatory cycles will be included

Exclusion criteria

* subjects with irregular life habits (shiftworkers and subjects having traveled across time zones less than one month prior to the beginning of the baseline study) * subjects taking any medication (including hormonal contraceptive therapy), and smokers are excluded * subjects with significant sleep apnea (apnea index above 10) or significant arousal-associated periodic leg movements are excluded

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026